A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection
Open Access
- 16 January 2007
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (3) , 985-990
- https://doi.org/10.1073/pnas.0609954104
Abstract
Cytokine polymorphisms are associated with disease outcome and interferon (IFN) treatment response in hepatitis C virus (HCV) infection. We genotyped eight SNPs spanning the entire IFN-γ gene in two cohorts and assessed the association between those polymorphisms and treatment response or spontaneous viral clearance. The first cohort was composed of 284 chronically HCV-infected patients who had received IFN-α-based therapy and the second was 251 i.v. drug users who had either spontaneously cleared HCV or become chronically infected. A SNP variant located in the proximal IFN-γ promoter region next to the binding motif of heat shock transcription factor (HSF), −764G, was significantly associated with sustained virological response [P = 0.04, odds ratio (OR) = 3.51 (confidence interval 1.0–12.5)]. The association was independently significant in multiple logistic regression (P = 0.04) along with race, viral titer, and genotype. This variant was also significantly associated with spontaneous recovery [P = 0.04, OR = 3.51 (1.0–12.5)] in the second cohort. Functional analyses show that the G allele confers a two- to three-fold higher promoter activity and stronger binding affinity to HSF1 than the C allele. Our study suggests that the IFN-γ promoter SNP −764G/C is functionally important in determining viral clearance and treatment response in HCV-infected patients and may be used as a genetic marker to predict sustained virological response in HCV-infected patients.Keywords
This publication has 41 references indexed in Scilit:
- Polymorphisms in the interferon-γ gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-α and ribavirinAntiviral Research, 2005
- Mechanism of action of interferon and ribavirin in treatment of hepatitis CNature, 2005
- Strategies for hepatitis C therapeutic intervention: now and nextCurrent Opinion in Pharmacology, 2004
- Role of cytokine gene polymorphism and hepatic transforming growth factor β1 expression in recurrent hepatitis C after liver transplantationCytokine, 2004
- Single nucleotide polymorphisms in the interferon-gamma and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virusLiver International, 2004
- Host factors and failure of interferon-α treatment in hepatitis C virusHepatology, 2004
- Chemokine Systems and Hepatitis C Virus Infection: Is Truth in the Genes of the Beholders?Hepatology, 2003
- Characterization of Hcv–Specific Patr Class Ii Restricted Cd4+ T Cell Responses in An Acutely Infected ChimpanzeeHepatology, 2003
- A New Statistical Method for Haplotype Reconstruction from Population DataAmerican Journal of Human Genetics, 2001
- Mutation screening of interferon‐gamma (IFNγ) as a candidate gene for asthmaClinical and Experimental Allergy, 1997